Evolution® Biliary Stent System-Fully Covered
Status: | Completed |
---|---|
Conditions: | Liver Cancer, Cancer, Cancer |
Therapuetic Areas: | Oncology |
Healthy: | No |
Age Range: | 18 - Any |
Updated: | 2/4/2017 |
Start Date: | September 2014 |
End Date: | January 4, 2017 |
Evaluation for the Effectiveness of Evolution® Biliary Stent System-Fully Covered
The Evolution® Biliary Stent System-Fully Covered study is a clinical trial approved by the
US FDA to evaluate the effectiveness of the Evolution® Biliary Stent System-Fully Covered
when used in palliation of malignant neoplasms in the biliary tree.
US FDA to evaluate the effectiveness of the Evolution® Biliary Stent System-Fully Covered
when used in palliation of malignant neoplasms in the biliary tree.
Inclusion Criteria:
- Inoperable malignant neoplasm causing biliary obstruction or stricture that requires
a fully covered metal stent
Exclusion Criteria:
- < 18 years of age
- Unwilling or unable to sign and date the informed consent
- Unwilling or unable to comply with the follow-up schedule
- Undergone or is planning to undergo brachytherapy with transpapillary or percutaneous
implantation of intracavitary radiation sources
- Participating in another investigational drug or device study in which patient has
not completed the follow-up phase for the primary endpoint at least 30 days prior to
enrollment
- Endoscopic procedures are contraindicated
- Current anatomy upstream of intended stent placement compromising the flow of bile
from the liver such that stent placement may not alleviate the biliary obstruction
symptoms
- Presence of a metal biliary stent
- Presence of an esophageal or duodenal stent
- Hypersensitivity/allergy or contraindication to any component of the stent, delivery
system, or medication required to complete the procedure,which in the investigator's
opinion cannot be adequately premedicated
- Coagulopathy
- Diffuse intrahepatic metastases that involves > 10 % of the liver
- Life expectancy of < 3 months
- Pregnant
- Active alcohol or substance abuse issue
- Jaundice secondary to a cause other than biliary duct obstruction
- Additional endoscopic restrictions as specified in the Clinical Investigation Plan
We found this trial at
8
sites
University of Pittsburgh Medical Center UPMC is one of the leading nonprofit health systems in...
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
University of Colorado Hospital, Site Top medical professionals, superior medicine and progressive change make University...
Click here to add this to my saved trials
University of Virginia Health System UVA Health System includes a 604-bed hospital, level I trauma...
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials